ライフサイエンスコーパス: narcotic

1 the endoscopist with benzodiazepine and/or a narcotic.

2 efined narcotics versus the predefined polar narcotics.

3 effects normally associated with the opiate narcotics.

4 ing the BBB in the physiological response to narcotics.

5 because of the side effects associated with narcotics.

6 s and were not using hormonal medications or narcotics.

7 was well tolerated, with continuous infusion narcotics.

8 e pain and perhaps obviate the need for oral narcotics.

9 performed on patients receiving preoperative narcotics.

10 evere, ultimately necessitating control with narcotics.

11 been demonstrated for several small-molecule narcotics.

12 fusion that resolved with discontinuation of narcotics), 3 (0.3%) cases of atelectasis, 2 (0.2%) corn

13 nesthesia, one patient required supplemental narcotics (5 mg of oxycodone) and sedatives (1 mg loreza

14 in smoking (n=6), marijuana use (n=79), oral narcotic abuse (n=20), and intravenous drug use (n=21).

15 roups codes, blood pressure, anesthetics and narcotics administered, surgical and anesthesia duration

16 Papaverine is a non-narcotic alkaloid found endemically and uniquely in the

17 The use of narcotics among patients with Crohn disease (CD) is ende

18 prohibited substances, including stimulants, narcotics, anabolic agents, diuretics, peptides, and gly

19 Use of patient-controlled narcotic analgesia and duration of use decreased (63.2%

20 omyalgia, approximately 50% of whom required narcotic analgesia and/or were disabled, treatment with

21 Intrathecal narcotic analgesia is used increasingly in fast-tracking

22 Narcotic analgesia was required in 98% of general anesth

23 n all cases of pain, patients were receiving narcotic analgesia.

24 have been shown to be effective adjuncts to narcotic analgesia.

25 Many changes relate to improvements in non-narcotic analgesic techniques and use of various suprala

26 Morphine, a potent narcotic analgesic used for the treatment of acute and c

27 atients) and reduction or discontinuation of narcotic analgesics (55% of patients), as well as improv

28 f entry onto the study, 15 patients required narcotic analgesics for bone pain; after treatment, eigh

29 s, and conservative therapy with bracing and narcotic analgesics gave little improvement.

30 Use and abuse of prescription narcotic analgesics have increased dramatically in the U

31 Identification of non-narcotic analgesics is of paramount importance.

32 Postoperative pain relief (freedom from narcotic analgesics) was achieved in 153 of 185 patients

33 ents, reduced dependence on narcotic and non-narcotic analgesics, improved performance status and qua

34 for non-pain conditions, are emerging as non-narcotic analgesics, supporting the repurposing of fingo

35 e less likely than whites to be treated with narcotic analgesics.

36 t alleles might display altered responses to narcotic analgesics.

37 bodies eliminated the pain and the need for narcotic analgesics.

38 lity improvement vs. control periods, use of narcotic and benzodiazepine infusions were substantially

39 sible), and performed chart review to assess narcotic and benzodiazepine use and time from ventilator

40 examine the developmental effects of various narcotic and neuropsychiatric-related risk factors withi

41 lity in many patients, reduced dependence on narcotic and non-narcotic analgesics, improved performan

42 Narcotic and psychotropic substances are natural, synthe

43 ter extubation, and respiratory arrest after narcotic and sedative medication.

44 Total doses of narcotics and benzodiazepines increased after implementa

45 (alcohols and anilines) with predefined MOA (narcotics and polar narcotics) were investigated at diff

46 ics, beta-2 agonists, diuretics, stimulants, narcotics, and beta-blockers) spiked in human urine and

47 Antibiotics, antimotility agents, narcotics, and non-steroidal anti-inflammatory drugs sho

48 nical management of postsurgical reversal of narcotic anesthesia and opioid side effects as well as t

49 d patients who lived in close proximity to a Narcotics Anonymous meeting location.

50 These results confirm that tertiary narcotic antagonist quaternization substantially reduces

51 Quaternary narcotic antagonists that are assumed not to penetrate t

52 gastrointestinal stimulants, antibacterials, narcotics, antipsychotics, inotropes, digoxin, anestheti

53 Opioid-based narcotics are the most widely prescribed therapeutic age

54 While morphine and other narcotics are the most widely prescribed therapy for mod

55 Application of the system to detection of narcotics at airport security control points is discusse

56 A newly described condition, Narcotic Bowel Syndrome (NBS)/Opioid-Induced GI Hyperalg

57 s warranted to determine the epidemiology of narcotic bowel syndrome and delineate the most efficacio

58 underlying pathophysiological mechanisms of narcotic bowel syndrome are incompletely understood; how

59 Narcotic bowel syndrome is characterised by worsening ab

60 Although narcotic bowel syndrome is rarely diagnosed, given the c

61 (DM) exposed to sublethal doses of presumed narcotic chemicals with log Kow >/= 1.8.

62 ecific mode of action and, surprisingly, for narcotic chemicals.

63 t may facilitate development of valuable non-narcotic clinical analgesics utilizing cotreatment with

64 Given that narcotics commonly are administered to patients after se

65 neous or individual detection of three major narcotic components, heroin, noscapine and morphine at m

66 a second-line therapy did not reduce overall narcotic consumption, but the overall narcotic use was l

67 en preparations simultaneously, and 63% used narcotic-containing compounds.

68 and toxicity tests using an assumed baseline narcotic critical body residue (CBR) and a range of orga

69 This study employs narcotics data and breast cancer data as demonstrative e

70 Narcotic dependence decreased and activity level increas

71 Severe pain/narcotic dependency, tumor size larger than 10 cm, and n

72 Apomorphine is a non-narcotic derivative of morphine, which acts as a dopamin

73 eatments for alleviating incisional pain and narcotic drug withdrawal symptoms, which are now in clin

74 intravenous propofol (2,6-diisopropylphenol, narcotic drug) infusion.

75 edures usually involve the administration of narcotic drugs as anesthetics or adjuvants.

76 le in mediating acute and chronic effects of narcotic drugs.

77 In order to circumvent the narcotic effects of Delta(9)-tetrahydrocannabinol (THC),

78 ployed field instrument for the detection of narcotics, explosives, and chemical warfare agents, drif

79 to extrinsic contamination of the parenteral narcotic fentanyl by a health care worker.

80 Intravenous infusion narcotics (fentanyl, morphine, or hydromorphone) were us

81 patients to decide whether or not to receive narcotics for pain control would result in fewer unneces

82 n modulation should be tried before starting narcotics for pain control.

83 a brief interval after receiving additional narcotics for pain during the procedure.

84 e tool for pain assessment; 2) administering narcotics for pain relief and benzodiazepines for anxiet

85 more immediate concerns when choosing opiate narcotics for pain therapy.

86 evious studies have used oral or intravenous narcotics for supplementation.

87 ly less likely to receive a prescription for narcotics for their symptoms than patients in the nonsta

88 block, preoperative carbohydrate loading and narcotic free pain regimens.

89 otably, at 12 months, the DC group was 91.7% narcotic-free, significantly higher than the NC group (P

90 recorded as being at work or as retrieving a narcotic from an automated dispensing cabinet in an area

91 neural dysfunction, inflammatory mediators, narcotics, gastrointestinal hormone disruptions, and ana

92 Moreover, misuse of prescription and illicit narcotics has resulted in the current opioid crisis.

93 Preoperative use of narcotics in patients undergoing abdominal surgery for C

94 Despite common use of narcotics in the clinical management of severe traumatic

95 The narcotic independence rate at 1 year was 55% and continu

96 ining physiological responsiveness to opioid narcotics is considered, micro opioids derived from salv

97 Since stress influences the potency of narcotics, it may be an important physiological componen

98 Narcotics may be needed to provide relief in some cases.

99 Only nine (4%) requested prescription narcotic medication at discharge, and no patient called

100 a standard scale ranging from 0 to 10), and narcotic medication use (intravenous morphine equivalent

101 ctive application of regional analgesia, non-narcotic medications, and complimentary alternative opti

102 Dividing the critical narcotic membrane burden of 100 mmol/kg by the experimen

103 the antinociceptive actions of the alkaloid narcotic, morphine, following either i.p. or intracerebr

104 has been shown to decrease operative times, narcotic need and permit quicker return of bowel functio

105 interval, 1.37-2.26), respectively, that of narcotic nonusers.

106 ive sleep apnea; b) to examine the effect of narcotics on postoperative obstructive sleep apnea.

107 g, sleeping) and required significantly less narcotic opioids (P < .001); improvement in the patient'

108 ent CES between July 2017 and June 2018 in a narcotic opt-in program.

109 -field sample testing of toxins, explosives, narcotics or other hazardous chemicals.

110 time, and 30% had not received any sedation, narcotic, or psychotropic drug in the previous 24 hrs.

111 r rate of infection or the use of sedatives, narcotics, or antibiotics in the catheter group.

112 Patients were assigned to receive either a narcotic- or a halothane-based anesthetic for adenotonsi

113 ough use of external data on (1) arrest, (2) narcotic overdose mortality, and (3) biomarker-based sen

114 y more control patients requested additional narcotics (P = 0.004), made unplanned calls (P = 0.009),

115 among those who did not receive prescription narcotics (P<0.0001).

116 ter ketorolac introduction required 58% less narcotics (P<0.001), recalled having less postoperative

117 generation of vapor samplers for explosives, narcotics, pathogens, or even cancer, and could inform f

118 Opt-In Narcotic Treatment (POINT) or routine narcotic prescription (control) was conducted at a singl

119 Many narcotic prescriptions are incompletely consumed, creati

120 tiatives to reduce the number of unnecessary narcotic prescriptions.

121 Patients were less likely to receive narcotics prescriptions from primary care providers when

122 ct and direct concern for research chemists: narcotic/psychotropic substances, chemical warfare-relat

123 trial, an opt-in strategy for postoperative narcotics reduced opioid prescription without increasing

124 1.22-1.43]; HR(high), 1.33 [1.17-1.53]) to a narcotics-related conviction (HR(moderate), 2.23 [2.14-2

125 To date, opioid narcotics represent the largest and most potent class of

126 formed to correlate clinical predictors with narcotic request.

127 ncision length (P = 0.007) as predictive for narcotic request.

128 eroidal anti-inflammatory drugs can decrease narcotic requirement and recovery time.

129 Perioperative outcomes and postoperative narcotic requirement were compared among patient groups.

130 es produced an analgesic effect that reduced narcotic requirements compared with patients who receive

131 End points included narcotic requirements, glycemic control, islet function,

132 Blood loss, length of stay, parenteral narcotic requirements, resumption of diet, and return to

133 d postoperative sensory block that minimizes narcotic requirements.

134 The International Narcotics Research Conference (INRC) has a rich history

135 up to the establishment of the International Narcotics Research Conference (INRC) in the early 1970s

136 research and the role that the International Narcotics Research Conference has played in driving this

137 ts the important role that the International Narcotics Research Conference has played in the evolutio

138 at the 50th anniversary of the International Narcotics Research Conference.

139 ministration, a significant reduction in the narcotic's ability to produce antinociception during str

140 eoperative prescription drug use (ie, use of narcotics, sedatives, and stimulants) have been establis

141 ient to identify threats like explosives and narcotics, since they can have a similar composition to

142 ative determination of 37 of the most common narcotic substances as well as the most commonly used ex

143 thought to be the cellular target of opioid narcotics such as morphine and heroin, mediating their e

144 Operative time, doses of narcotics, surgical difficultly and hospital charges wer

145 ector genomic surveillance, (4) allergen and narcotic surveillance, (5) antimicrobial resistance surv

146 ription, we reduced the number of prescribed narcotic tablets by 96.6%.

147 achieved a 96.6% reduction in the number of narcotic tablets prescribed, and a 98% reduction in unco

148 ion and assessments of strategies to prevent narcotics tampering in all health care settings are need

149 ressants, pain killers, anti-psychotics, and narcotics that are poor substrates for microsomal CYP1A1

150 Employing 22 organic narcotics that cover 7.2 units of their log K(ow) (octan

151 For patients taking long-term narcotics, the mean use per week was 639 mg (95% CI, 220

152 ting the S1P axis towards development of non-narcotic therapeutics, which, in turn, will hopefully he

153 eral nutrition (TPN), and days of injectable narcotic therapy (all over 28 days), days in hospital (o

154 0001), (4) 2.6 additional days of injectable narcotic therapy (P <.0001), (5) 2.6 additional days in

155 r antagonists may improve the reliability of narcotic therapy.

156 ion of potent short-acting beta-blockers and narcotics to control hemodynamic variables are examples

157 "a physician providing a sufficient dose of narcotics to enable a patient to kill himself." Responde

158 to minimize the contribution of prescription narcotics to the nationwide opioid epidemic, reductions

159 tanding the intrinsic mechanisms involved in narcotic tolerance and dependence.

160 avenues for the study and treatment of pain, narcotic tolerance, and dependence.

161 ve the first indications of the link between narcotic toxicity and the chemical activity of organic c

162 mized clinical trial of Postoperative Opt-In Narcotic Treatment (POINT) or routine narcotic prescript

163 its use is restricted to federally licensed narcotic treatment programs (NTPs).

164 efore their TP-IAT was 7.1 +/- 0.3 years and narcotic usage of 3.3 +/- 0.2 years.

165 room (3.2 vs 4.7, P = .003), interval total narcotic use (6.7 vs 12.5 mg, P = .003 at <4 hours and 0

166 = .01 at 8-12 hours), and total intravenous narcotic use (9.2 vs 17.2 mg of morphine sulfate equival

167 of stay (4 versus 7 days), and decreased IV narcotic use (all P < 0.05.Postoperative morbidity was e

168 (P = 0.01), depression (P < 0.001), baseline narcotic use (P = 0.004), highest pain postoperatively (

169 as associated with reduced LOS and decreased narcotic use after donor nephrectomy.

170 significantly reduces postoperative pain and narcotic use after LVHR.

171 Overall narcotic use also decreased by nearly 50% (45.6 vs. 21.3

172 rbidity, as well as significant decreases in narcotic use and cost.

173 s a consequence of enviromimetic modeling of narcotic use and neuropsychiatric-related risk factors i

174 months 9 and 12 after randomization, with no narcotic use and no further sphincter intervention.

175 Among adult patients, the odds of narcotic use at 1 year were increased by previous endosc

176 on the outcome implications of prescription narcotic use before kidney transplantation.

177 in patients that is associated with illicit narcotic use by health care workers.

178 It is widely accepted that narcotic use during pregnancy and specific environmental

179 reatic pain" similar to preoperative levels, narcotic use for any reason, and islet graft failure at

180 Patients with preoperative narcotic use had a longer mean (SD) length of stay (11.2

181 7% of evaluable patients, with a decrease in narcotic use in 56%.

182 There was a significant increase in narcotic use in control patients in the first 24 hours (

183 measures were pain over 6 hours, parenteral narcotic use over 24 hours, duration of hospitalization,

184 Pain scores were lower and 24-hour narcotic use was less in patients who received lidocaine

185 verall narcotic consumption, but the overall narcotic use was low in both groups.

186 ariable analysis indicated that preoperative narcotic use was the only independent risk factor associ

187 onor recipients with the highest quartile of narcotic use were 2.3 times (aHR, 2.27; 95% confidence i

188 variate analysis, patients with a history of narcotic use were 7.5 times more likely to opt in (95% C

189 y, wake-up times, emetic symptoms, pain, and narcotic use were compared.

190 Patients with a history of chronic narcotic use were excluded.

191 nalog pain scales) and subjective (mobility, narcotic use) scores were monitored before and after ver

192 ssociated with significant reduction in i.v. narcotic use, a rapid return to diet, and shorter hospit

193 were gathered regarding ethanol abuse, pain, narcotic use, and recurrent acute exacerbations requirin

194 omitant depression, chronic pain, alcohol or narcotic use, and/or take several preparations simultane

195 racture progression had significantly higher narcotic use, change in Karnofsky performance score, and

196 Laparoscopic approach, narcotic use, length of stay, 30-day readmission, ileus

197 Before starting regular narcotic use, patients with CD should be considered for

198 ience through improved pain control and less narcotic use, without increased length of stay or compli

199 ermine what effect this may have on pain and narcotic use.

200 ct on postoperative anxiety, pain levels, or narcotic use.

201 ere observed in postoperative pain levels or narcotic use.

202 d clinical variables, including preoperative narcotic use.

203 ductions in bone turnover markers, pain, and narcotic use.

204 ietary habits, self-reported medical status, narcotics use, and SES indicators.

205 rs, mechanical ventilation, benzodiazepines, narcotics, use of physical restraints, and exposure to v

206 Subgroup analysis indicated that outpatient narcotic users had increased incidence of adverse postop

207 rative outcomes compared with inpatient-only narcotic users.

208 up is designed for a quick identification of narcotics using automated sampling.

209 points were patient-reported outcomes, total narcotic utilization, and complications.

210 result in a classification of the predefined narcotics versus the predefined polar narcotics.

211 omated dispensing cabinet in an area where a narcotic was administered to each of the 3 case patients

212 The relief from narcotics was sustained.

213 forcement Administration's list of scheduled narcotics was used to query opioid use.

214 centers, and we hypothesized that excessive narcotics were being dispensed on discharge.

215 Concomitant tricyclic antidepressants and/or narcotics were continued if therapy was stabilized prior

216 nal surgery, and chronic preoperative use of narcotics were independently correlated with POI on mult

217 Patients receiving narcotics were more likely to have a current smoking hab

218 ial confidence interval: 63%, 100%) for whom narcotics were prescribed prior to the procedure reporte

219 es) with predefined MOA (narcotics and polar narcotics) were investigated at different levels of biol

220 ounds were significantly lower than those of narcotics, whereas no differences were found between end

221 nd some insight into the pharmacokinetics of narcotics while on uteroplacental support has been gaine

222 Serious adverse events included the narcotic-withdrawal syndrome and sirolimus-associated pn

223 tients who had at least 1 pharmacy claim for narcotics within 1 month before surgery was 41.5 years a

224 profound analgesic properties of intrathecal narcotics without motor blockade make them an excellent